Anthracycline-free neoadjuvant therapy with nab-paclitaxel and carboplatin in nonluminal breast cancer: a single-arm phase II trial

被引：0
|
作者：
Liu, Deyue
Zhu, Li
Wu, Jiayi
Wang, Wei
Ding, Shuning
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-18-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-18-09
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
    Tanaka, Hisashi
    Taima, Kageaki
    Morimoto, Takeshi
    Tanaka, Yoshihito
    Itoga, Masamichi
    Nakamura, Kunihiko
    Hayashi, Akihito
    Kumagai, Mika
    Yasugahira, Hideo
    Mikuniya, Megumi
    Okudera, Koichi
    Takanashi, Shingo
    Tasaka, Sadatomo
    BMC CANCER, 2017, 17
  • [22] Nab-paclitaxel and cisplatin-based concurrent chemoradiotherapy for locally advanced cervical cancer: A prospective, single-arm phase II clinical trial
    Li, Mingyi
    Qin, Qinghua
    Zhang, Yiqian
    Wu, Qiuyan
    Li, Zhouyu
    Yang, Xinglong
    Cai, Zhantuo
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S72 - S72
  • [23] A Phase II Trial of Neoadjuvant nab-paclitaxel, Carboplatin, and Gemcitabine (ACaG) in Patients With Locally Advanced Carcinoma of the Bladder
    Grivas, Petros D.
    Hussain, Maha
    Hafez, Khaled
    Daignault-Newton, Stephanie
    Wood, David
    Lee, Cheryl T.
    Weizer, Alon
    Montie, James E.
    Hollenbeck, Brent
    Montgomery, Jeffrey S.
    Alva, Ajjai
    Smith, David C.
    UROLOGY, 2013, 82 (01) : 111 - 117
  • [24] ABLE: single-arm trial of nab-paclitaxel with ANTI-PD1 in advanced urothelial cancer
    Brown, Jason
    Daignault, Stephanie
    Reichert, Zachery R.
    Palmbos, Phillip Lee
    Alva, Ajjai Shivaram
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [25] NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
    Shishir K. Maithel
    Jessica M. Keilson
    Hop S. Tran Cao
    Manali Rupji
    Amit Mahipal
    Bruce S. Lin
    Milind M. Javle
    Sean P. Cleary
    Mehmet Akce
    Jeffrey M. Switchenko
    Flavio G. Rocha
    Annals of Surgical Oncology, 2023, 30 : 6558 - 6566
  • [26] Neoadjuvant anlotinib plus nab-paclitaxel based chemotherapy in patients with HER2-negative breast cancer: A prospective, single-arm, single-center, phase II clinical study
    Fan, Jing
    Wang, Ting
    Meng, Huimin
    Li, Songpeng
    Kong, Jing
    Wang, Yidi
    CANCER RESEARCH, 2023, 83 (05)
  • [27] Multicenter phase II trial of neoadjuvant carboplatin, weekly nab-paclitaxel, and trastuzumab in stage II-III HER2+breast cancer: A BrUOG study
    Sinclair, Natalie Faye
    Sakr, Bachir Joseph
    Abu-Khalaf, Maysa M.
    Somlo, George
    Black, Robert C.
    Chung, Gina G.
    Rizack, Tina
    Strenger, Rochelle
    Fenton, Mary Anne
    DiGiovanna, Michael
    Constantinou, Maria
    Lannin, Donald R.
    Legare, Robert Duffy
    Chagpar, Anees B.
    Sambandam, Sundaresan T.
    Bossuyt, Veerie
    Rosati, Kayla
    Harris, Lyndsay
    Sikov, William M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Phase II trial of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
    Yizhao Xie
    Chengcheng Gong
    Jian Zhang
    Leiping Wang
    Jun Cao
    Zhonghua Tao
    Ting Li
    Yannan Zhao
    Yi Li
    Shihui Hu
    Biyun Wang
    Xichun Hu
    BMC Cancer, 21
  • [29] A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer
    Liu, Ting
    Li, Qing
    Lin, Zhen
    Liu, Chunhua
    Pu, Wei
    Zeng, Shasha
    Lai, Jun
    Cai, Xuebin
    Zhang, Lisha
    Wang, Shuyang
    Chen, Miao
    Cao, Wei
    Gou, Hongfeng
    Zhu, Qing
    CANCER RESEARCH AND TREATMENT, 2024, 56 (02): : 602 - 615
  • [30] Nab-paclitaxel followed by dose-dense epirubicin/cyclophosphamide in neoadjuvant chemotherapy for triple-negative breast cancer: an open-label, single-arm phase II study
    Liu, Yin
    Fan, Lei
    Shao, Zhi-Ming
    Wang, Zhong-Hua
    CANCER RESEARCH, 2023, 83 (05)
12345